Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimenSydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
Blood|April 18, 2018
Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 reportAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Leukemia|June 28, 2018
Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2Anna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Leukemia|February 20, 2024
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS reportAnna Sällfors Holmqvist, Qingrui Meng, Chen Dai, et al.
Blood|August 24, 2007
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intoleranceHagop M Kantarjian, Francis Giles, Norbert Gattermann, et al.
Cell Reports|April 12, 2018
JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor CellsSihui Li, Shafat Ali, Xiaotao Duan, et al.
Leukemia & Lymphoma|October 10, 2025
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemiaBenjamin McCormick, Anthony Findley, Kendall Diebold, et al.
JAMA Oncology|January 19, 2023
Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow TransplantAndrew McDonald, Chen Dai, Qingrui Meng, et al.
Transfusion|August 24, 2007
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantationShirong Wang, Auayporn Nademanee, Dajun Qian, et al.
JAMA Oncology|July 29, 2018
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in ChildhoodAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|July 26, 2023
Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimenSydney Dunn-Valadez, Srilakshmi Bathini, Kathleen E Purdy, et al.
Blood|April 18, 2018
Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 reportAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Leukemia|June 28, 2018
Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2Anna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Leukemia|February 20, 2024
Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults-a BMTSS reportAnna Sällfors Holmqvist, Qingrui Meng, Chen Dai, et al.
Blood|August 24, 2007
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intoleranceHagop M Kantarjian, Francis Giles, Norbert Gattermann, et al.
Cell Reports|April 12, 2018
JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor CellsSihui Li, Shafat Ali, Xiaotao Duan, et al.
Leukemia & Lymphoma|October 10, 2025
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemiaBenjamin McCormick, Anthony Findley, Kendall Diebold, et al.
JAMA Oncology|January 19, 2023
Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow TransplantAndrew McDonald, Chen Dai, Qingrui Meng, et al.
Transfusion|August 24, 2007
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantationShirong Wang, Auayporn Nademanee, Dajun Qian, et al.
JAMA Oncology|July 29, 2018
Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in ChildhoodAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Pageof 22